SMTL ID : 5vli.1

Computationally designed inhibitor peptide HB1.6928.2.3 in complex with influenza hemagglutinin (A/PuertoRico/8/1934)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.80 Å
Oligo State
hetero-3-3-3-mer
Ligands
3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
3 x PGF: 2,5,8,11-TETRAOXATRIDECANE(Non-covalent)
9 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Chevalier, A. et al., Massively parallel de novo protein design for targeted therapeutics. Nature (2017)
Release Date
2017-09-27
Peptides
Hemagglutinin: ADG
Hemagglutinin: BEH
Computationally designed peptide HB1.6928.2.3: CFI
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
D
A
G
A
B
B
E
B
H
B
C
C
F
C
I
C

Hemagglutinin

Toggle Identical (ADG)

Hemagglutinin

Toggle Identical (BEH)

Computationally designed peptide HB1.6928.2.3

Toggle Identical (CFI)

Related Entries With Identical Sequence

5w5s.1 | 5w5u.1 | 5w6i.1 | 5w6r.1 | 5w6r.2 | 5w6t.1 | 5w6u.1 | 6wcr.1